An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans
This study of Medicare Part D plans offered in 2006 examines formularies, drug costs and utilization management tools in drug plans offered by 14 national and near-national organizations. Collectively, these organizations account for 1,222 of the 1,429 Part D plans available to Medicare beneficiaries.
The analysis finds that Medicare’s new, private, stand-alone drug plans vary significantly in terms of covered drugs, out-of-pocket costs for specific medications and restrictions placed on the use of certain drugs.
The study was conducted by Jack Hoadley of Georgetown University, Elizabeth Hargrave of NORC at the University of Chicago, and Juliette Cubanski and Tricia Neuman of the Kaiser Family Foundation.
also of interest
- Medicare at a Glance
- Medicare Part D in Its Ninth Year: The 2014 Marketplace and Key Trends, 2006-2014
- Seniors' Knowledge and Experience With Medicare's Open Enrollment Period and Choosing a Plan: Key Findings from the Kaiser Family Foundation 2012 National Survey of Seniors
- Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006